Procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass produce average weight reductions of 25 to 35% and remain the most durable interventions available for severe obesity and obesity-related metabolic disease
Available from: Gouvrion L, Delage M, Villani AP, Le Naour S, Fite C, Cassius C, et al
Cell 54 , 516528.e517 (2020)
If youre serious about your training or if youre a coach YOU DO NOT WANT TO MISS THIS because you wont get a better opportunity to learn from two of the best
With 16 new drugs potentially launching in the next five years, it is anticipated that new challengers will account for roughly $70 billion of the total incretin-based drug market, which is expected to reach $200 billion by 2031
Further research is essential to discover new strains, optimize dosing regimens, confirm safety, and validate health claims through robust clinical trials